Green Sky Labs
Green Sky Labs (GSL) is a biotech company founded in 2014 that develops disruptive technologies and commercializes them through subsidiaries. GSL focuses on improving the global healthcare sector with a genomic-based AI and quantum platform for clinical trials, point-of-care solutions, and personalized consumer health. Their subsidiaries include My Next Health (genomics-driven digital therapeutics), Agentix Biosciences (pharmaceutical and nutraceuticals), Nectar Health Sciences (cannabinoid isolation technology), and Kalmex Inc. (membrane-based technology for cannabinoid extracts). The company emphasizes patient-focused development of custom cannabinoid formulations and leverages partnerships to validate research.
Green Sky Labs
Green Sky Labs (GSL) is a biotech company founded in 2014 that develops disruptive technologies and commercializes them through subsidiaries. GSL focuses on improving the global healthcare sector with a genomic-based AI and quantum platform for clinical trials, point-of-care solutions, and personalized consumer health. Their subsidiaries include My Next Health (genomics-driven digital therapeutics), Agentix Biosciences (pharmaceutical and nutraceuticals), Nectar Health Sciences (cannabinoid isolation technology), and Kalmex Inc. (membrane-based technology for cannabinoid extracts). The company emphasizes patient-focused development of custom cannabinoid formulations and leverages partnerships to validate research.